Background: Portal hypertension (PH), defined by hepatic venous pressure gradient (HVPG) 5 mmHg and clinically significant PH, defined by HVPG 10 mmHg, are complications of chronic liver disease. Purpose: To assess the diagnostic performance of MR elastography (MRE) and dynamic contrast-enhanced MRI (DCE-MRI) of the liver and spleen for the prediction of PH and clinically significant PH, in comparison with a qualitative PH imaging scoring system. Study Type: IRB-approved prospective study. Population: In all, 34 patients with chronic liver disease who underwent HVPG measurement. Field Strength/Sequence: 1.5/3T examination including 2D-GRE MRE (n 5 33) and DCE-MRI of the liver/spleen (n 5 28). Assessment: Liver and spleen stiffness were calculated from elastogram maps. DCE-MRI was analyzed using model-free parameters and pharmacokinetic modeling. Two observers calculated qualitative PH imaging scores based on routine images. Statistical Tests: Imaging parameters were correlated with HVPG. Receiver operating characteristic (ROC) analysis was performed for prediction of PH and clinically significant PH. Results: There were significant correlations between DCE-MRI parameters (liver time-to-peak, r 5 0.517 / P 5 0.006, liver distribution volume, r 5 0.494 / P 5 0.009, liver upslope, r 5 -0.567 / P 5 0.002), liver stiffness (r 5 0.478 / P 5 0.016), PH imaging score (r 5 0.441 / P 5 0.009), and HVPG. ROC analysis provided significant area under the ROC (AUROCs) for PH (liver upslope 0.765, liver stiffness 0.809, spleen volume/diameter 0.746-0.731, PH imaging score 0.756) and for clinically significant PH (liver and spleen perfusion parameters 0.733-0.776, liver stiffness 0.742, PH imaging score 0.742). The ratio of liver stiffness to liver upslope had the highest AUROC for diagnosing PH (0.903) and clinically significant PH (0.785). Data Conclusion: These preliminary results suggest that the combination of liver stiffness and perfusion metrics provide excellent accuracy for diagnosing PH, and fair accuracy for clinically significant PH. Combined MRE and DCE-MRI outperformed qualitative imaging scores for prediction of PH. Level of Evidence: 1 Technical Efficacy: Stage 2
defined as an HVPG 5 mmHg, and clinically significant PH is defined as an HVPG 10 mmHg. 3 The presence of clinically significant PH has been shown to carry a high risk of complications, such as variceal bleeding and ascites. 4 Direct HVPG measurement is not widely available and is relatively invasive and costly, with potential complications, which limit its use in clinical practice, especially for patient follow-up. Thus, there is a need for noninvasive methods to predict portal pressure in patients with chronic liver diseases.
In this context, several noninvasive tests are under investigation to evaluate if they could replace, or decrease the need for, HVPG measurement. Several parameters have been proposed, including platelet count, spleen size (and their combination), serum markers, Child-Pugh score, presence of esophageal varices on upper gastrointestinal endoscopy, or imaging composite score (based on the presence of varices, spleen size, presence of ascites), with variable accuracy. The highest accuracy has been reported for the ratio between platelet count and spleen size (area under the receiver operating characteristic [AUROC] 0.64-0.93). [5] [6] [7] [8] [9] Liver stiffness measurement acquired through ultrasound elastographic methods (transient elastography or acoustic radiation force impulse [ARFI] / shear wave elastography [SWE]) or magnetic resonance elastography (MRE) has been most often used for liver fibrosis staging. 10, 11 Liver stiffness measurement using transient elastography has been shown to be a robust tool for PH diagnosis, with AUROC between 0.76 and 0.99. 5, [12] [13] [14] ARFI and SWE have demonstrated a slightly better diagnostic value, but are still limited by failures in obese patients and in patients with ascites. 15, 16 Spleen stiffness has been proposed for PH assessment in most recent studies. The increase in spleen stiffness is likely due to splenic congestion secondary to the increase in portal pressure. Spleen stiffness is a potentially attractive parameter, due to the lack of confounding factors (such as liver congestion, biliary obstruction, liver inflammation, cellular infiltration, deposition of amyloid), compared to liver stiffness. Spleen stiffness measurement using ultrasound elastography methods is promising but has a high failure rate, which limits its uses. 16, 17 MRE for liver and spleen stiffness measurements has also been tested, with studies showing a strong correlation between both liver and spleen stiffness and portal pressure in pigs, weak to moderate correlation between both liver and spleen stiffness and HVPG, or with the grade of esophageal varices. 18, 19 Moreover, liver and spleen stiffness measurements with MRE show high reproducibility between MRI field strengths, systems, and observers. 20, 21 In parallel to the liver and spleen stiffness increase, advanced liver fibrosis and cirrhosis can cause hemodynamic changes, with increased splanchnic inflow, hepatic resistance and portal pressure, and decreased portal flow secondary to increased hepatic resistance and the development of portosystemic collaterals. 22 This decrease of the portal flow is associated with an increase of the arterial flow, known as the hepatic arterial buffer response. 23 The role of Doppler measurement for PH assessment is limited due to the high variability of the measurement. 24 Annet et al suggested the use of flow parameters obtained from dynamic contrastenhanced (DCE)-MRI for noninvasive portal pressure assessment. 25 They found that portal fraction, portal blood flow, and mean transit time were substantially correlated with portal pressure, and that liver blood flow, arterial blood flow, and distribution volume/hepatic artery resistance index transit time were weakly correlated with portal pressure. 25 The aim of our initial study was to assess the diagnostic performance of MRE and DCE-MRI of the liver and spleen for the prediction of PH and clinically significant PH in patients with liver disease.
Materials and Methods

Patients
This single-center prospective study was compliant with the Health Insurance Portability and Accountability Act and approved by the local Institutional Review Board. Written informed consent was obtained from all subjects. From April 2012 to August 2016, 34 patients with chronic liver disease (M/F 16/18) with a mean age of 53 years (range 26-75 years) who underwent HVPG measurements were consented to the study protocol.
Clinical Data
The following clinical parameters were recorded for all patients at the time of their MRI exam: age, sex, weight, body mass index (BMI), and etiology of chronic liver disease.
HVPG Measurements
HVPG measurements were performed either before or after the MRI (78 6 48 days, range 3-184 days) by one of five experienced interventional radiologists. Right transjugular access was obtained using ultrasound guidance, under local anesthesia and moderate conscious sedation. A 5F 65-cm MPA diagnostic catheter (Cordis, Bridgewater, NJ) was used to catheterize the right or middle hepatic vein, and venography was performed with iodinated contrast. Then a 5.8F 1.0-cm flow-directed occlusion balloon (Cook Medical, Bloomington, IN) catheter was placed in the middle or right hepatic vein. The HVPG was calculated as the difference between wedged and free hepatic venous pressures. Free pressure was measured in the vein with the balloon deflated. Measurements were obtained after 45-60 seconds to allow for equilibration using an NAMIC Preceptor transducer (Navilyst Medical, Marlborough, MA). Then the balloon was inflated to profile in the vein and the wedge pressure was measured using the same transducer. Two measurements were performed, and an average value was determined.
MRI Acquisition
The MRI acquisitions were performed on either a 1.5T clinical system (Siemens Aera, Siemens Healthineers, Erlangen, Germany, n 5 19) or using the combination of a 1.5T (Siemens Avanto, Siemens Healthineers) and 3.0T systems (General Electrics MR 750, GE Healthcare, Waukesha, WI) (n 5 15). Each system is equipped with a 32-channel spine and flexible body array coil for signal reception. Subjects were asked to fast for 6 hours prior to imaging to eliminate postprandial effects on portal venous blood flow. 27 In cases for which a combination of systems was used, MRE was first performed on the 3.0T system followed by DCE-MRI and additional standard sequences, performed on the 1.5T system. In addition to MRE and DCE-MRI, the MRI protocol also included the following standard sequences: axial and coronal single-shot T 2 -weighted imaging; axial fat-suppressed fast spin echo T 2 -weighted imaging; axial 3D T 1 -weighted imaging in-and outof-phase, axial diffusion-weighted imaging; and 3D T 1 -weighted imaging breath-hold fat-suppressed spoiled gradient-recalled echo sequence before and at a delayed phase (4 min) after injection of a gadolinium-based contrast agent. The acquisition parameters for MRE and DCE-MRI are listed in Table 1 .
DCE-MRI acquisition consisted of 100 dynamic acquisitions of a T 1 -weighted 3D-FLASH volumes covering the liver and spleen, before and after an intravenous injection of gadolinium-based contrast agent (0.05 mmol/kg of gadobenate dimeglumine; Multihance, Bracco Diagnostics, Princeton, NJ), followed by a 25-ml saline flush, at a rate of 3 ml/s. The injection began 8 seconds after the start of the acquisition. Because of the high relaxivity of gadobenate dimeglumine, a half dose of the contrast agent was used to avoid saturation of the signal intensity in the DCE-MRI acquisition. 26 , matrix 128 3 88, parallel imaging generalized autocalibrating partially parallel acquisition [GRAPPA] acceleration 2) was used to provide quantitative T 1 mapping in 1-2 slices through mid-liver in a single 18-second breath-hold.
For liver and spleen MRE acquisitions, two 19-cm diameter passive acoustic drivers were placed both at the level of the xiphoid, one on the right side of the abdomen to measure liver stiffness and the other one posteriorly to the left side to measure spleen stiffness. Two different acquisitions were performed. Four axial slices were centered over the portal vein for the liver acquisition and the splenic hilum for the spleen acquisition. A modified phase contrast gradient recalled echo (GRE) sequence was used with motion encoding gradients along the z-axis. The acquisition time was 55 seconds, split into four breath-holds for each location. The stiffness maps and a confidence index (ranging from 0-100%) for stiffness measurement were automatically provided by the software. MRE was performed before the contrast injection. MRE failure was defined as the absence of visualized wave propagation on the wave images and/or no pixel with a confidence index higher than 95% on the confidence map. 27 
MRI Analysis
DCE-MRI ANALYSIS. First, motion correction was applied to the DCE-MR images with 3D rigid registration using open-source image analysis software (Firevoxel, CAI 2 R, New York University, New York, NY) by observer 1 or observer 2 (MRI physicists with 2 and 4 years of experience). Second, free-hand regions of interest (ROIs) were drawn in the right hepatic lobe (centered on the portal bifurcation) and the portal vein on the liver-registered images, the spleen parenchyma (centered on the spleen hilum) on the spleen-registered images, and the aorta at the level of the celiac trunk on the unregistered images, on five slices, by two observers in consensus (observer 1 and observer 3, a body radiologist with 6 years of experience in abdominal imaging) to measure signal intensity (SI, in arbitrary units). Then the signal-time intensity curves were extracted and analyzed using MatLab (v. R2015a, MathWorks, Natick, MA). In order to reduce inflow artifacts in the mean SI curve in the aorta, a locally weighted linear least-square fit with first degree polynomial (LOWESS) was applied on the curve of the aorta, as described previously. 28 A quantitative analysis was performed using a dual-input single compartment model described by Materne et al for the liver and a Tofts model for the spleen. 32, 33 The following estimated parameters were computed for the liver: arterial flow (F a , ml/100g/ min), portal venous flow (F p , ml/100g/min), total hepatic flow (F t , ml/100g/min), mean transit time (MTT, sec), distribution volume (DV, %), and arterial fraction (ART 5 F a /F t , %); for the spleen: transfer constant (K trans , min 21 ), extravascular extracellular space (v e , %), and rate constant (k ep , min 21 ). In addition, model-free parameters were obtained for both the liver and spleen: time-topeak (TTP, sec), peak concentration (C peak , mmol/L), area-underthe-curve at 60 sec (AUC60, mmol/L.s), and upslope (mmol/ (L.s)).
MRE ANALYSIS. MRE analysis was performed by observer 3 using Osirix software (v. 5.5.2, Geneva, Switzerland). Free-hand ROIs were drawn in the liver and spleen parenchyma, as large as possible, avoiding voxels with confidence index less than 95% and large vessels, liver/spleen edge, fissures, and regions of ambiguous wave propagation. Stiffness values were extracted for the liver and spleen, and an average organ stiffness value, weighted by the ROI size, was computed from all four slices.
ADDITIONAL MRI ANALYSIS. Two radiologists (observer 3 and observer 4, a radiologist with 3 years of experience in abdominal imaging) independently reviewed the MR images on PACS (Centricity, GE Healthcare). The observers were blinded to the initial radiological reports, HVPG, and pathology results. They were asked to compute a fast semiquantitative imaging-based PH score, ranging from 0 to 9, according to Kihira et al, 6 which has been shown to provide fair accuracy for prediction of PH and clinically significant PH. The imaging score is based on the number of variceal sites (0: absence of varices, 1: one variceal site, 2: two variceal sites, and 3: 3 or more variceal sites), volume of ascites (0: no ascites, 1: minimal perihepatic and perisplenic fluid, 2: intraperitoneal fluid without marked abdominal wall distension, and 3: fluid causing marked abdominal wall distension), and maximum craniocaudal diameter of the spleen (0: size less than 13 cm, 1: size between 13 and 15 cm, 2: size between 15 and 20 cm, and 3: size greater than 20 cm). Finally, observer 3 measured the spleen volume through manual segmentation on axial single-shot T 2 -weighted imaging, using Osirix Software (v. 5.5.2).
Statistical Analysis
Quantitative variables are presented as median (interquartile range, IQR). Categorical variables are presented as number of cases (percentage of cases). The statistical difference between parameters in patients with and without PH, and patients with and without clinically significant PH, was assessed using Mann-Whitney U-tests. Correlations between MRI parameters and HVPG were assessed using Spearman correlation analysis. ROC analysis was performed for prediction of PH (HVPG 5 mmHg) and clinically significant PH (HVPG 10 mmHg). Finally, general linear modeling with stepwise selection of features was employed to select the most predictive (combination of ) parameters for assessment of PH and/or clinically significant PH. Only parameters that showed significance between no PH and PH and between no clinically significant PH and clinically significant PH were included as potential variables for the general linear model to avoid overfitting. A two-tailed Pvalue less than 0.05 was considered significant. Statistical analyses were performed using SPSS software (v. 20, Chicago, IL), except the general linear modeling, which was performed using MatLab (v. R2016B).
Results
Patients
Among the 34 patients, two patients did not have DCE-MRI acquisition due to chronic renal insufficiency, four patients had non-usable DCE-MRI data because of major artifacts, and one patient did not have MRE acquisition. Patient characteristics are presented in Fig. 1 ) There was a moderate significant correlation between liver stiffness (r 5 0.486, P 5 0.006) and HVPG measurement. Among the DCE-MRI parameters, liver DV, liver TTP, and liver upslope were all significantly correlated with HVPG measurement (r 5 0.494, P 5 0.009, r 5 0.517, P 5 0.006, and r 5 -0.567, P 5 0.002, respectively). Liver T 1 was not significantly correlated with HVPG (r 5 0.049, P 5 0.809).
None of the spleen parameters were significantly correlated with HVPG measurement, except for spleen volume and spleen craniocaudal diameter, which showed weak nonsignificant correlations with HVPG measurement (r 5 0.309 and 0.311, P 5 0.075 and P 5 0.073, respectively). The PH qualitative score of both observers were moderately correlated with HVPG measurements (r 5 0.441-0.484, P 5 0.004-0.009).
Diagnostic Accuracy for Diagnosing PH (HVPG 5 mmHg)
Liver upslope and liver TTP were the only liver perfusion parameters significantly different between patients with and without PH; it was significantly decreased and increased, respectively, in PH (P 5 0.027 / P 5 0.035). The qualitative PH score, liver stiffness, spleen volume, and spleen craniocaudal diameter were all significantly higher in patients with PH (Table 4 ). The AUROC analysis is presented in Table 5 . Liver stiffness had the highest AUROC (0.809) for diagnosing PH.
Diagnostic Accuracy for Diagnosing Clinically Significant PH (HVPG 10 mmHg) Liver TTP, liver DV, and spleen TTP, liver stiffness and the qualitative PH score were all significantly increased in patients with clinically significant PH compared to patients 
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without clinically significant PH, while liver upslope was significantly decreased (Table 4 , Fig. 2 ). Spleen upslope was decreased and spleen craniocaudal diameter was increased in patients with clinically significant PH, with a trend towards significance (P 5 0.095 / P 5 0.086). The AUROC analysis is presented in Table 5 . To differentiate patients with and without clinically significant PH, for the significant parameters, AUROCs were 0.75.
Combination of Noninvasive Methods
Similar to Kim et al 34 on the basis of the above results, we combined DCE-MRI and MRE parameters that showed the best correlation with HVPG (liver upslope and liver stiffness). As liver upslope was negatively correlated with HVPG, it was used as the denominator, and as liver stiffness was positively correlated with HVPG, it was used as the numerator, in order to emphasize their relationship with HVPG. The new parameter was called LSLU and was computed as ratio of liver stiffness to liver upslope. LSLU was strongly and significantly correlated with HVPG (r 5 0.650, P < 0.0001) (Fig. 1) Only parameters with significant AUROCs are listed. DV: distribution volume, LSLU: ratio of liver stiffness and liver upslope, TTP: time to peak.
0.903 (P 5 0.001) with sensitivity of 78% and specificity of 100% (using cutoff 433) ( To diagnose clinically significant PH using LSLU, we observed AUROC of 0.785 (P 5 0.023), sensitivity of 88%, and specificity of 72% (using cutoff 469) ( Table 5 ). According to the general linear modeling, the combination of liver stiffness and liver upslope showed high accuracy for prediction of PH (accuracy 0.769). However, this combination did not outperform liver stiffness alone (accuracy 0.807). For clinically significant PH, spleen TTP was the best predictor (accuracy 0.778) (Table 6) .
Finally, we assessed the number of patients with clinically significant PH missed by liver stiffness that were correctly diagnosed with the qualitative score and vice versa. Using liver stiffness, there were four false-negative cases for clinically significant PH (among the nine cases of clinically significant PH assessed with liver stiffness), including two correctly diagnosed with the qualitative score (Fig. 3) . Using the qualitative score, there were three false-negative cases; none of them was correctly diagnosed by liver stiffness. 
Discussion
In this initial prospective study, we showed that the combination of liver stiffness and perfusion parameters has the potential to identify patients with PH (with excellent accuracy) and clinically significant PH (with fair accuracy). Several liver perfusion/flow modifications are known to occur in chronic liver disease and cirrhosis. The increase of the liver resistance and portal pressure are responsible for a decrease in portal flow and an increase in arterial flow, as shown previously by Annet et al. 25 Contrary to Annet et al, we did not find any significant correlation or modification in the portal blood flow, arterial blood flow, or arterial fraction in PH and clinically significant PH. 25 Of note, these correlations were not always described in other studies. 35, 36 These discrepancies could be explained by the high variability of the modeled DCE-MRI parameters and the small sample size. 37 Yet we found that liver upslope, liver TTP, and liver DV correlated significantly with HVPG measurements. The increase of liver TTP and the decrease of liver upslope in PH is concordant with the decrease in liver perfusion in advanced liver disease. None of the spleen DCE-MRI parameters correlated with HVPG measurements, with only a trend found for spleen TTP. The published data on spleen perfusion quantification in PH is limited, with variable results. 35, 38, 39 The absence of correlation between spleen blood flow and HVPG is not in accordance with two previous studies, which found a decrease of splenic blood flow in PH. 35, 38 Similarly, a relationship between spleen K trans and HVPG was also observed previously, but not reproduced in our study. 35, 39 The splenic perfusion modifications in case of PH could be linked to an increased interstitial pressure in the splenic tissue, which may increase the blood transit time, decrease the capillary permeability, and the blood flow. The absence of correlation in our study may be due to differences in modeling or imaging modality (computed tomography [CT] vs. MRI). Liver stiffness was significantly correlated with HVPG and higher in patients with PH, in accordance with previous results either with ultrasound or MRE. 5, [13] [14] [15] [16] 18 Despite the potential confounding factors, such as liver fibrosis stage, liver stiffness seems to be the best parameter for identification of patients with PH. Moreover, MRE is an attractive method because it does not require contrast injection, and has a high success rate (at 1.5T using a GRE sequence and at 3T using a spin echo sequence). 27, 40, 41 Our newly described combined parameter, LSLU, combining liver stiffness measured with MRE and liver upslope, could improve performance of MRE for the diagnosis of PH (with sensitivity of 78% and specificity of 100%). However, it did not improve the performance of liver MRE for clinically significant PH. The added value of LSLU should be studied in a larger sample.
The general linear modeling identified the combination of liver stiffness and liver upslope as a good predictor for PH. However, this combination did not outperform liver stiffness, which had the best accuracy. For prediction of clinically significant PH, spleen TTP alone was the best predictor according to the general linear modeling.
We found that spleen stiffness was not able to identify patients with PH. The literature on spleen stiffness in PH is conflicting. Spleen stiffness is considered by certain authors to be a promising parameter, due to fewer confounding factors compared to liver stiffness. For example, Ronot et al showed that the viscoelastic parameters of the spleen allowed the identification of patients with severe PH (defined by HVPG 12 mmHg) and those with high-risk varices. 18 Similarly, Shin et al found a significant correlation between spleen stiffness and grade of esophageal varices. 19 The discordance between their results and ours may be related to the fact that they used 3-directional MRE, while we used 1-directional MRE. The 1-directional MRE sequence was designed for the liver and 3-directional MRE has been suggested to be more appropriate for spleen anatomy. 18, 19 As expected, the spleen volume and craniocaudal spleen diameter were significantly higher in PH; however, it did not correlate significantly with HVPG. The increase of spleen diameter and volume have been previously described, with variable accuracy. 6, 35, 42 Both, and especially the spleen diameter, are attractive because they are easy to obtain. However, as previously shown, they seem more accurate when combined with other parameters. 6, 42 In addition, we confirmed-as in Kihira et al's study-the diagnostic accuracy of the qualitative PH score for PH and clinically significant PH assessment. 6 The qualitative score is easy to assess and could be an alternative to more advanced methods, even if it performs less well than the advanced methods. It could also be useful to identify patients with clinically significant PH missed by MRE. Our study has several limitations to be acknowledged. First, the sample size was small, reflecting our initial experience. Our results need to be validated in a larger study. Second, all patients did not undergo examination with each imaging modality because of failure, contraindications, or availability. Third, different platforms were used for MRI acquisition. Some studies have reported that interplatform reproducibility is close to the repeatability. 20, 43 Moreover, for DCE-MRI, the 1.5T systems used are from the same vendor, so we can expect a high reproducibility between those two systems, as we used similar 3D GRE sequences and an identical injection protocol. Fourth, we used MRE with one direction of motion, while most studies on spleen stiffness used MRE with three directions of motion. However, only MRE with one direction of motion was available at our institution at the time of the study. Fifth, the interval between HVPG and MRI may be quite long. However, logistically, it was not possible to scan the patients within a few days of the HVPG measurement, but all patients had no treatment in the time interval. Finally, we did not include endoscopic findings in our study.
In conclusion, our preliminary results suggest that combined liver stiffness and perfusion metrics provide excellent accuracy for diagnosing PH, and fair accuracy for clinically significant PH. Combined MRE and DCE-MRI outperformed qualitative PH imaging scores for prediction of PH. These results need confirmation in a larger study.
